Mirtazapine for Cats

Mirtazapine (brand names: Mirataz for cats; Remeron in people) is a prescription-only appetite stimulant and anti‑nausea medication for cats. It’s commonly prescribed to help manage unwanted weight loss, poor appetite, or nausea related to illnesses like kidney or GI disease, and can also be used when appetite is reduced during chemotherapy. Mirataz (the ear ointment) is FDA‑approved specifically for cats; human tablets are sometimes used extra‑label under a veterinarian’s direction. Common effects owners may report include increased meowing/vocalization, restlessness or drowsiness, vomiting, and mild ear redness at the application site. If an owner says the cat hasn’t eaten anything for more than 48 hours (or much less than usual for several days), this warrants a same‑day veterinary call; severe agitation, tremors, overheating, or very fast heart rate are emergency red flags. For exact use instructions and to check for drug interactions, your veterinarian can discuss what’s appropriate for that individual cat.

What owners ask most: 1) When will it help my cat eat? Many cats show more interest in food within 1–2 days; responses vary. If your cat isn’t improving or has stopped eating, your veterinarian can discuss next steps. 2) What side effects are normal? The most commonly reported are increased meowing/restlessness, occasional vomiting, and mild ear skin irritation where the ointment is applied. 3) Is the ear ointment safe around family and other pets? Yes—when used correctly: apply with disposable gloves, then keep people and other animals from touching your cat for 2 hours so the medicine can absorb. 4) Can it be used with other meds? Your veterinarian will review all medications and supplements; Mirataz should not be used with monoamine oxidase inhibitors (MAOIs). Escalation guidance for owners: Contact us the same day if your cat has repeated vomiting, severe agitation/restlessness, tremors, trouble breathing, or if another pet or a person is exposed to the ointment. Seek emergency care now if your cat collapses, has continuous tremors/seizures, or breathing difficulty. Do not change, start, or stop any medication without veterinary guidance; after stopping Mirataz, monitor appetite—if your cat eats much less for several days or stops eating for more than 48 hours, contact your veterinarian.

What owners most often report after starting mirtazapine (including Mirataz ointment) are behavior changes such as “more talkative” (increased meowing), restlessness or hyperactivity, and sometimes mild drowsiness. With the ointment, mild ear skin changes at the application site (redness/crusting) are common. Some cats may vomit or drool if they lick/groom the medication. These effects are usually short‑lived. Your veterinarian can discuss what’s expected for the individual patient. Call the clinic the same day if the cat has marked or persistent agitation, nonstop vocalizing, shaking/tremors, unsteady walking, fast or labored breathing, a racing heartbeat, repeated vomiting, or heavy drooling—these can be signs of sensitivity or too much drug. Signs can begin within hours of a dose and often resolve within 12–48 hours, but worsening or severe signs need prompt veterinary guidance. Escalate immediately to emergency care if there is collapse, seizures, or severe breathing trouble. Special notes for Mirataz: after it is discontinued, monitor food intake. If the cat eats much less than usual for several days or stops eating for more than 48 hours, contact the veterinarian. If the ear skin becomes very red, scabby, or painful at the application site, please call for guidance. Your veterinarian can advise next steps and whether any medication changes are needed.

Available forms: Most cats receive mirtazapine either as a transdermal ear ointment (brand Mirataz) or by mouth (tablet; some clinics/pharmacies can compound a flavored liquid or small capsule). For the ear ointment, staff should remind clients to wear gloves, apply only to the inner ear flap (not down the canal), alternate ears, wash hands after, and keep people and other pets from touching the treated area for about two hours. If any skin gets exposed, wash with soap and water. Your veterinarian can show the exact amount to apply and where. [Do not provide dosing from the front desk.]. Oral tips: Mirtazapine by mouth can be given with or without food; if a cat vomits when it’s given on an empty stomach, future doses may go better with a small meal. Pilling tricks you can suggest: hide the pill in a small soft treat (pill pocket), lightly coat the pill with a tiny bit of butter or soft food to help it slide, use a pet piller device if needed, and offer a small lickable treat or a few sips of water afterward to help it go down. If giving liquids, go slowly and to the side of the mouth to avoid choking. Your veterinarian can discuss additional options if pilling is stressful, including compounding. Troubleshooting and when to call: If the cat spits out a dose, vomits soon after a dose, or refuses medication, do not give an extra dose—have the client call for veterinary guidance. Ask the veterinarian about compounding options (flavored liquid/capsule/chew). Note that non‑FDA‑approved compounded ear gels made from bulk mirtazapine are not FDA‑reviewed; any compounding should be discussed with the prescribing veterinarian. Escalate immediately if the cat shows severe agitation, continuous vocalizing, tremors, or repeated vomiting—advise the client to seek urgent veterinary care. Your veterinarian can advise on next steps and whether any medication changes are needed.

Mirtazapine is an Rx-only appetite stimulant/anti‑nausea medicine used in cats. The FDA‑approved feline product is Mirataz (transdermal ointment). A valid veterinarian‑client‑patient relationship (VCPR) is required for prescriptions and refills. Mirataz is labeled for short courses in cats; if a cat needs ongoing help with appetite or nausea, the veterinarian will decide on recheck timing and whether continued refills are appropriate. Do not promise a refill until the doctor reviews the record. Standard refill workflow: collect cat’s name, DOB, and owner contact; exact medication and form (e.g., Mirataz ointment or mirtazapine tablets), how many doses/days are left, preferred pharmacy, and a brief status update (appetite/weight trends and any side effects such as ear redness/irritation for ointment, increased vocalization, agitation, vomiting, tremors, or unsteady walking). Typical turnaround is 1–2 business days; sooner if the pet is nearly out or the doctor flags a needed recheck. For online pharmacies, confirm the specific product requested; Mirataz is the FDA‑approved veterinary ointment, while some compounded transdermal versions made from bulk drug are unapproved and must be specifically approved by the veterinarian. The veterinarian can discuss whether an in‑person recheck is due and the expected refill interval for that patient. Escalate the call immediately if the caller reports severe restlessness/agitation, tremors, unsteady gait, rapid breathing/heart rate, collapse, or if the cat has not eaten for more than 48 hours—advise same‑day veterinary assessment or referral to emergency care. For any concerns or unusual side effects, defer to the veterinarian for guidance.

Escalate to a veterinarian or technician immediately for any of the following after mirtazapine (Mirataz/Remeron): trouble breathing, facial swelling or hives, collapse, or seizures—these can indicate a severe allergic reaction or serious toxicity. Also treat as urgent if the cat ingested a human mirtazapine tablet, chewed the Mirataz tube, or licked a large amount of ointment, due to overdose risk. Your veterinarian can discuss next steps and whether poison control should be contacted. Watch for a toxicity/serotonin-like cluster: nonstop or intense vocalizing, marked restlessness or agitation, pacing, tremors/shaking, unsteady walking, vomiting, drooling, very fast breathing, or very fast heart rate; dilated pupils or overheating may also occur. These signs can begin within minutes to a few hours of a dose or accidental ingestion—get medical staff immediately. Escalate urgently if the owner reports the cat is using or was recently exposed to monoamine oxidase inhibitors (selegiline), amitraz products (collars/dips), tramadol, or SSRIs (e.g., fluoxetine), as these raise the risk for serotonin syndrome. Same-day escalation is also appropriate for severe ear redness/swelling or open sores at the application site, or persistent vomiting or profound lethargy.

Key interaction flags for mirtazapine (Mirataz/Remeron) in cats: alert the veterinarian if the owner mentions any serotonergic or MAOI-type drugs. These include fluoxetine or other SSRIs, trazodone, tramadol, buspirone, and monoamine oxidase inhibitors such as selegiline; exposure to amitraz (some collars/dips) also counts as MAOI-type. Combining serotonergic drugs can precipitate serotonin syndrome; urgent signs to listen for include agitation/restlessness, tremors or twitching, dilated pupils, vomiting/diarrhea, rapid heart rate, or a high temperature. Manufacturer and FDA information also warn not to use Mirataz with MAOIs and to use caution in cats with kidney or liver disease; any potential interaction should be reviewed by the veterinarian before continuing therapy. Commonly co-prescribed meds you may hear: anti-nausea agents (maropitant/Cerenia, ondansetron/Zofran), stomach acid reducers (famotidine/Pepcid; note that cimetidine/Tagamet can raise mirtazapine levels), pain/anxiety sedatives (gabapentin, benzodiazepines like diazepam), and analgesics (buprenorphine; tramadol is serotonergic and is a flag). These combinations are often used under veterinary direction, but increased sedation can occur with other sedating medicines, and serotonin-risk combinations must be flagged immediately. Your veterinarian can discuss whether the specific combo, timing, and monitoring plan are appropriate for that patient. OTC or home-use items to ask about and flag as needed: cough/cold syrups containing dextromethorphan (serotonin risk), cimetidine/Tagamet (can increase mirtazapine levels), sedating antihistamines such as diphenhydramine (additive drowsiness), and herbal/supplements that affect serotonin (e.g., St. John’s wort, 5-HTP). If the owner reports urgent signs consistent with serotonin syndrome, escalate to immediate emergency veterinary care while notifying the veterinarian.

Mirataz (mirtazapine transdermal ointment): store at room temperature below 77°F (25°C). It’s a multi‑use tube that must be discarded within 30 days after first opening. Keep the cap on tightly, do not freeze, and avoid getting the ointment on skin. Wear disposable gloves to apply, wash hands after, and keep people and other pets from contacting the treated cat for 2 hours after application. Your veterinarian can confirm any clinic‑specific handling steps or alternatives if a different formulation is dispensed. Mirtazapine oral tablets (e.g., Remeron/generic): store at 68–77°F (20–25°C), protect from light and moisture, and keep the bottle closed tightly. Use tablets until the pharmacy/vial expiration date. If dispensing orally disintegrating tablets, leave each tablet in its original blister until use. For any compounded mirtazapine products, follow the storage and beyond‑use date printed on the compounding pharmacy label; if unclear, the veterinarian can advise. Child/pet‑proofing and disposal: keep all mirtazapine in its original labeled, child‑resistant container and in a secure, pet‑proof location (not on counters or nightstands). Store pet meds separately from human meds to avoid mix‑ups. Dispose of unused/expired medication via a drug take‑back program when possible. If no take‑back is available, do not flush; mix the medication with an undesirable substance (used cat litter or coffee grounds), seal in a bag/container, and place in household trash; remove personal information from packages. If a person or another pet is exposed (skin contact with ointment or any ingestion), contact your veterinarian or an emergency clinic immediately; you can also call Pet Poison Helpline (855‑764‑7661), ASPCA Animal Poison Control (888‑426‑4435), or human Poison Control (800‑222‑1222) for guidance.

Scheduling: Plan a brief recheck near the end of the initial treatment period so we can record weight, ask about appetite, and note any side effects or ear skin changes. Cats with known liver or kidney disease, or cats expected to need repeated courses, may have veterinarian-directed lab checks (for example, liver enzymes or kidney values) and more frequent weigh-ins; the veterinarian will set the exact timing for your patient. No routine bloodwork is required solely because a cat is on mirtazapine, but the plan is individualized by the prescriber. Home monitoring: Appetite should generally improve within 1–2 days of starting therapy. Monitor appetite and weight, and especially watch food intake after the medication is stopped; some cats may eat less after discontinuation. Call us if there is no meaningful improvement in appetite after a couple of days, or if you see notable side effects such as ear redness/irritation, increased vocalizing, hyperactivity, vomiting, or marked sedation—your veterinarian can discuss whether any adjustments or additional testing are needed. Escalation: Same-day evaluation is needed if the cat stops eating for more than 48 hours, is eating less than a quarter of normal for several days, or shows concerning neurologic signs such as agitation, incoordination, or tremors; if after-hours, direct the owner to the nearest emergency clinic. Use extra caution and defer questions about monitoring frequency to the veterinarian for cats with liver or kidney disease.

Mirtazapine (brand Mirataz for cats) is a prescription medication used to help stimulate appetite and reduce nausea. Mirataz is the FDA‑approved transdermal ointment for cats and is applied to the inner ear by the pet parent as directed by the care team. For safety, owners should wear disposable gloves, wash hands after application, and prevent contact between the treated ear and people or other pets for 2 hours after each dose. Human mirtazapine (e.g., Remeron) is not labeled for cats; questions about formulations or how to give it should be directed to the medical team. ([fda.gov](https://www.fda.gov/animal-veterinary/animal-health-literacy/helping-our-cats-live-healthier-lives-information-about-fda-approved-drugs-cats?utm_source=openai)) Front‑desk quick answer and triage: Common, usually mild effects include increased meowing/vocalization, restlessness or hyperactivity, vomiting, and ear redness at the application site. If the cat is extremely agitated, trembling, collapses, has trouble breathing, or has a seizure—or if a child or another pet had direct contact with the freshly treated ear—advise the caller to seek emergency care now. For non‑urgent concerns (mild side effects, how/when to give, refills, or appetite drops after stopping—especially if the cat eats little or nothing for more than 2 days), arrange a same‑day call with the medical team; the veterinarian can discuss side effects, potential drug interactions (e.g., with MAOIs), and whether any changes are appropriate. Phrases to avoid: “It’s safe to start/stop or give extra,” “Use your own Remeron,” “It’s over‑the‑counter,” or any dosing instructions—defer these to the veterinarian. ([drugs.com](https://www.drugs.com/vet/mirataz-mirtazapine-transdermal-ointment.html?utm_source=openai))